Based in Tampa, Florida, Virginia Pelley is a former women's magazine editor who has written health and fitness content for Men's Journal, Cosmopolitan magazine, the Chicago Tribune, ...

Strattera (atomoxetine) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). Strattera comes as an oral capsule. Strattera is used in adults and certain ...

Strattera vs. Ritalin: What Is the Difference? Strattera and Ritalin are medicines that children and adults can take to manage symptoms of attention deficit hyperactivity disorder (ADHD). Both drugs ...

Eli Lilly and Company announced today that it has added a warning to Strattera (search), an attention deficit hyperactivity disorder (ADHD) medication. Lilly says Strattera should be stopped in ...

Strattera is a non-stimulant medication for ADHD that works by increasing norepinephrine in your brain. Common side effects of Strattera include dry mouth, nausea, and reduced appetite. Stimulants ...

Eli Lilly and Company (NYSE: LLY) announced today that the United States Food and Drug Administration (FDA) has approved Strattera® (atomoxetine HCI) for ...

The Food and Drug Administration warned doctors Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit ...

THE POWER of marketing can clearly be seen in the case of Strattera, Eli Lilly's new drug for attention deficit/hyperactivity disorder. The company is hoping its drug will help fill the gap left in ...

Strattera, an attention deficit hyperactivity disorder treatment manufactured by Eli Lilly, will carry a "black box" warning based on a review of earlier clinical trials that found the drug might ...

Eli Lilly and Co., the world’s biggest maker of psychiatric drugs, won a court order banning generic versions of the attention-deficit treatment Strattera until a patent appeal is decided. The U.S.

An Australian researcher wrongly told a university ethics committee that Eli Lilly's Strattera did not have a black box warning label in an application for a trial of the drug in children. At the same ...